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ABSTRACT
This article presents a systematic framework for modeling several classes of 
illness-sickness-disease named as Holopathogenesis. Holopathogenesis is 
defined as processes of over-determination of diseases and related conditions 
taken as a whole, comprising selected facets of the complex object Health. 
First, a conceptual background of Holopathogenesis is presented as a series 
of significant interfaces (biomolecular-immunological, physiopathological-
clinical, epidemiological-ecosocial). Second, propositions derived from 
Holopathogenesis are introduced in order to allow drawing the disease-
illness-sickness complex as a hierarchical network of networks. Third, a 
formalization of intra- and inter-level correspondences, over-determination 
processes, effects and links of Holopathogenesis models is proposed. Finally, 
the Holopathogenesis frame is evaluated as a comprehensive theoretical 
pathology taken as a preliminary step towards a unified theory of health-disease.
DESCRIPTORS: Health. Disease. Health-Disease Process. 
Comprehensive Health Care. Holistic Health.
RESUMO
Este trabalho apresenta uma abordagem sistemática para a modelagem 
de várias classes de enfermidade-moléstia-doença, designada como 
Holopatogênese. Holopatogênese é definido como um processo de sobre-
determinação de doenças e condições relacionadas, tomadas como um 
integral, compreendendo facetas selecionadas da saúde enquanto objeto 
complexo. Em primeiro lugar, o marco conceitual da Holopatogênese é 
apresentado como uma série de três interfaces significativas: biomolecular-
imunológica, fisiopatológico-clínica e epidemiológico-ecossocial. Em 
segundo lugar, proposições derivadas da Holopatogênese são introduzidas 
a fim de permitir o desenho do complexo doença-enfermidade como uma 
rede hierárquica de redes. Em terceiro lugar, propõe-se uma formalização 
de correspondências intra- e inter-nível, processos de sobredeterminação, 
efeitos e laços componentes da Holopatogênese. Finalmente, o modelo 
Holopatogênese é avaliado como uma patologia teórica compreensiva tomada 
como passo preliminar para uma teoria unificada de saúde-doença.
DESCRITORES: Saúde. Doença. Processo Saúde-Doença. Assistência 
Integral à Saúde. Saúde Holística.
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Several authors1,13-14,41,45,52,68-69,74,82,84 have emphasized 
the importance of new theoretical models articulated 
into broader, comprehensive scientific paradigms, 
needed for understanding concrete health problems and 
developing efficient technologies to solve them.18,27,53 
Dominant approaches to theory building of health-
disease processes and phenomena, such as evolutionary 
biology12,20,30 or theoretical pathology,29,36,44,54,77 still rein-
force reductionist, linear models of disease. Indeed, 
objects of knowledge of health-disease-care have been 
defined poorly and inadequately, because conventional 
theoretical frameworks do not take into account holism 
and complexity.76
In this context, subdisciplines of applied human 
biology have claimed priority to define health-
disease as a scientific object. Molecular biology takes 
genome and proteome as the only valid themes of 
research, arguing that all other levels of pathological 
processes flow from basic molecular and biochem-
ical systems.21,37,81 Histopathology and immunology 
demand the centrality of tissular or intra-systemic 
levels in pathogenesis, given that lesions and altera-
tions constitute causes of signs and symptoms that 
supposedly define what disease is.27,36 Physiopathology, 
assigned as the basic clinical science, invoke unbal-
anced or pathological regulatory mechanisms to 
explain causality of diseases and, therefore, to domi-
nate the knowledge object.67,77 In each case, advocates 
reduce other fields and levels to their respective object 
and method, advertising their own as the only capable 
to produce scientifically valid knowledge.44
Along these lines, a reductionist concept of disease can 
be stated as follows:
Disease is a defect in the molecular structure of 
cells, producing lesion at tissue level, resulting in 
alteration of function of organs and systems, which 
causes pathology, expressed objectively as signs and 
symptoms in individuals that, as cases accumulate 
additively in diseased groups, conform morbidity 
in populations and sickness in societies.
The influence of Cartesian mechanism is evident in 
this depiction.41,44 In this approach, society and popula-
tions are reduced to the mere sum of individuals, whose 
bodies are taken as a functional set of systems and 
organs. Systems and organs are in turn reduced to struc-
tures of differentiated tissues formed by cell units, which 
are treated as biochemical micro-mills of molecules. 
Indeed, neo-Cartesian theories of disease can subsi-
dize efficient technological solutions of limited scope, 
as exemplified by linear simulation models of cells and 
metabolic systems taken as a “virtual lab” to test new 
molecules with therapeutic purposes.64,79 But the utility 
of such models is very restricted due to several reasons. 
INTRODUCTION
To say the least, pathologies of major social, ecological 
or population impact surpass the molecular, subindi-
vidual and clinical realm and challenge the validity of 
classical reductionism as an approach to understand the 
nature of illness66 and disease.22,38
Due to the dependence of these models, theories and 
approaches upon their own validation patterns, concep-
tual validity is limited to the respective level of patho-
genesis. Indeed, the holistic complex nature of health-
related objects such as disease has been dealt with 
inadequately in scientific practice.1-5,8,18,31,35,38,46,73 The 
reduction of complexity of health-disease processes 
to unidimensional concepts related to molecular 
and subindividual biological levels – as mutations, 
lesions, microorganisms, clinical causes and the like 
– has led to a double drawback. On the one hand, 
neo-Cartesian reductionism prevents a better under-
standing of phenomena and processes related to 
bio-socio-environmental interactions.25 On the other 
hand, linear approaches neglect multiple properties 
that define disease and health as a plural and multi-
dimensional complex that requires rigorous scientific 
investigation.1,6,10,19,38
To overcome reductionism, contemporary episte-
mologists16,71 interested in health as a scientific object 
propose that disease belongs to a set of phenomena 
defined by non-linear dynamics, interconnected with 
many different systems, themselves at distinct structural 
levels.31,34 As a complex of phenomena related to life, 
health, cure and care, disease-illness-sickness may be 
formalized as a system of states.13,15-17,28,45,47,50,67-69,72-74,78
As reviewed elsewhere,5 complexity analysis has 
often been used in research designed to study hier-
archical levels and dynamic interactions in health. 
In this connection, either in the artificial intelligence 
domain,75 in the bio-molecular field76 or in the ecolog-
ical sphere,31,55 new analytical tools and mathematical 
devices are certainly welcome to model health-disease 
complexity. Although not yet hegemonic in the health 
field, this scientific approach is more pertinent for 
considering complex systems into data analysis of 
pathogenesis and associated events.
Given the growing awareness of the role of complexity 
in nature and in history, key questions are at stake: 
What is the acceptable scope for contemporary theo-
ries of health-disease? Should they be catalogues of risk 
factors or clinical etiology profiles? Should they afford 
to be mere letters of intent for just another modeling 
of agent, host and environment? Would researchers 
continue insisting in straightforward thin thinking, 
satisfied with engineering expensive (but unreliable) 
magic bullets or with manufacturing smart biocards? 
What should be the role of biomolecular markers 
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interacting with complex environmental contexts in 
these explanatory frames? How social determination 
and cultural diversity could be integrated into these 
theoretical models?
In this series of articles,8 we assume that disease-illness-
sickness should be studied as a composite, synthetic 
object that makes sense only in its integrity. In order to 
pursue alternative theoretical strategies such as complex 
modeling of health-disease phenomena through non-
linear, comprehensive, holistic models, I have proposed 
mapping disease as a special kind of ontological object 
that depends on heuristic substrates for its constitu-
tion.4,6 Conceptually and epistemologically, a general 
theory of health does not stand without “special theo-
ries” of disease. Therefore, a restricted theory of disease 
and related conditions is needed to approach the many 
facets, manifestations and expressions of such complex 
object of knowledge.
Following up on such preliminary accounts, in this 
article, I present in a more systematic fashion a frame-
work for modeling several classes of illness-sickness-
disease, named as Holopathogenesis (HPG) theory. 
First, assumptions, levels and components are discussed 
as a conceptual background to HPG, needed for 
supporting definitions of significant interfaces between 
biomolecular and immunological, physiopathological 
and clinical, epidemiological and ecosocial realms. 
Second, a series of propositions derived from HPG is 
introduced in order to allow drawing the disease-illness-
sickness complex as a hierarchical network of networks. 
Third, a formalization of the intra- and inter-level 
correspondence, over-determination, effects and links 
of HPGT models is proposed. Finally, the HPG frame 
is evaluated as a comprehensive theoretical pathology 
taken as a preliminary step towards a unified theory of 
health-disease.
Axiomatic background
Given the baseline scenario, disease is an object ideally 
construed in its broader configuration, because different 
facets or angles give access to it, although none of such 
angles by itself gives access to the object in its entirety.74 
In this regard, disease should be considered as, simul-
taneously, cluster component of ecosystem structures, 
chain of sensitive points in a conditioned network, state 
resulting from a web of determined biological mecha-
nisms, outcome of multiple causes or relationships that 
generate risk.26 But disease also has meaning, with a 
strong symbolic, metaphorical component, being sick-
ness its representation in the realm of social relations and 
illness its subjective, intimate, personal manifestation.40,42
As a conceptual tool, the disease concept can be 
approached as both an ontological and a heuristic 
model-object.24,28,39 In this framework, mutant genes 
and altered metabolism are ontological models of 
disease designed to refer to events and phenomena of 
pathology or disease. In turn, immunogenic models 
and homeostatic systems comprise heuristic models 
because they represent explanatory sets of determinants 
or causal processes.
The phenomenological domain for any given science, 
defined as an empirical field, may be devised as planes 
of emergence and corresponding levels of organization 
(or complexity), following patterns that depend upon 
the nature of the research object.49 Such a diversity of 
levels and planes allows for coupling distinct disci-
plinary fields, corresponding to hierarchical interfaces, 
each with particular validation rules and determination 
models. For the core object of health sciences, Samaja70 
(2000, p. 96) outlines four value-spaces: bio/social, 
social/cultural, economic/societal, ecological/polit-
ical. These orders can be condensed into two signifi-
cant hierarchical orders – bio-individual and socio-
cultural, which are composed by levels and interfaces 
with varied degrees of specificity. The bio-individual 
hierarchical order (Biho) is a set of levels of occur-
rence of health-disease phenomena taken as material 
effects of biological environmental determinants. The 
ordering of this set, from the least to the most complex 
level, is as follows:
Biho = molecule>->cell>->tissue>->organ>-
>system>->organism 
>->group>->population >->environment
Regarding biological organisms belonging to the human 
species, primates commonly designated as “human 
beings” who are capable of creating and operating 
language, culture and technology, one of the tiers of 
this order is superimposed to other possible orders, 
such as the symbolic order. The tier organism-group-
population-milieu may be read as subject-family-
society-culture, forming a sociocultural hierarchical 
order (Scho), such as:
Scho = molecule>->cell>->tissue>->organ>-
>system>->subject 
>->family>->society>->culture
Figure 1 presents a visual diagram that allows compar-
ison between the two hierarchical orders, composed by 
contiguous planes. A superimposition of subindividual 
levels is evident. However, replacing the individual 
organism by the human subject changes the character of 
each supra-individual plane of emergence. For example, 
given the symbolic significance of parental links, a 
family is more than a group of individuals. Although 
formed by populations, considering political aspects of 
social relations, societies should not be reduced to mere 
demographic aggregates. Finally, there is a fundamental 
contradiction between environment and culture, as far 
as nature is radically and continuously transformed by 
the praxis of the human species.
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In so-called health sciences, Biho axis is typically over-
valued, underestimating the Scho axis in its heuristic 
function and therefore scientific validity. Respectful of 
the complexity and wholeness of phenomena of life and 
health, we ought to integrate levels/facets of both hier-
archical orders into a totalizing, integral, hierarchical 
set of planes of occurrence. Merging Biho and Scho 
orders generates a 7-uple composite scale of disease-
health states:
I. [MSt] Micro-structural – molecule to cell
II. [MSy] Micro-systemic – metabolism and tissues
III. [SbI] Subindividual – body systems
IV. [Cas] Individual – clinical cases
V. [PaR] Epidemiologic – population at risk
VI. [EcS] Environmental – ecosystems
VII. [SoC] Symbolic – semeiologic and cultural
The concept of ‘health-disease integral’ (HDI) was 
proposed and analyzed previously.8 To advance further, 
consider the following set of assumptions:
1. HDI refers to the general set of health-disease-care 
phenomena and processes affecting human bodies, 
human subjects and human populations.
2. HDI is concretely expressed as a complex Disease-
Illness-Sickness (cDIS) in levels and components 
because health-disease-care phenomena and processes 
occur simultaneously at different scales of reality.
3. Health-disease-care phenomena and processes exist 
if, and only if, they are determined in a given way; 
therefore, cDIS does not exist per se.
4. Holopathogenesis (HPG) engenders cDIS as an 
integral object-model.
5. HPG is a system of states, ruled by processes of 
over-determination and emergence, represented by 
a net-network (networks of networks).
Etymologically, the concept of ‘holopathogenesis’ is 
herewith defined as a network or a set of processes 
of over-determination (genesis) of diseases, sick-
nesses and conditions related (pathos) taken as an 
integral, complex, total object (holos), comprising 
distinct facets, manifestations and expressions of such 
a complex object of knowledge. Built around a class 
of peculiar heuristic object-models, HPG operates at 
distinct hierarchical levels of complexity, dependent of 
its ontological and symbolic subject matter.
Conceptual framework
Axiomatically, no disease is autonomous and discrete 
in ontological terms; HDI exists only if determined. 
However, the ways HDI is determined are dependent 
upon the facet/level of the object-model considered. The 
representation of distinct facets of a total ontological object 
demands corresponding but specific heuristic models.16
HPG models are polisemic, multifaceted, plural, simul-
taneously ontological and heuristic objects. As such, 
they cut across distinct patterns and domains refer-
ring to different components and levels of complexity, 
constructed for (and by) reference to phenomena 
produced (and referenced) by basic health sciences, 
simultaneously bioclinical and sociocultural. Biological 
models of determination have structural or systemic 
components and processes, operating on different 
levels (molecule, cell, tissue, organs, and systems).54,77 
Clinical models of disease are based on mechanistic 
or causal models referred to the individual level.27,65,67 
Epidemiological and ecosocial pseudo-probabilistic 
models are drawn from population and environmental 
levels.19,43,46,60 Linguistic and symbolic models of health-
sickness-care are anchored in the realm of language 
and culture.40,63
Figure 1. The biodemografical and sociocultural hierarchical orders.
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Following the composite scheme of hierarchical dimen-
sions proposed above, HPG models are formed by a set 
of seven planes of occurrence, corresponding to different 
ƒ-facets or sub-spaces and levels of pathogenesis. At 
the microstructural dimension MSt, HPG is expressed 
concretely as molecular or cellular phenomena. HPG is 
manifested at a microsystemic MSy dimension, in the 
metabolism or tissue; at subindividual levels (SbI), as 
physiopathological processes in organs or body systems; 
at the clinical dimension in individual “cases” (Cas), at 
the epidemiological dimension of the population at risk 
(PaR), in environmental interfaces of ecosystems (EcS), 
in symbolic or sociocultural grounds (SoC).
Each level of HPG implies components of a given class 
of determination, with its corresponding HDI-states. In 
this model, pathological processes, health states and 
correlates are determined by the set of determinants 
(causes, factors, determinants, over-determinants or 
emergent forces) or by the articulate action of different 
determinant sets, and by the values assumed by those 
variables vis à vis resistance (capabilities, resilience, 
strength, among others) of the affected dimension (cell, 
organ, body, group, milieu, among others).
HPG results from “agonistic” dyads formed by the 
tension between holopathogens and body defenses as 
components of over-determination networks, which 
generically can be distributed in two sub-groups, patho-
gens and resistors. The first group is formed by deter-
minants that promote the occurrence of pathological 
components, which we name as holopathogens (H), 
and the second one by determinants that raise resis-
tance to disease spread or avoidance of emergency of 
non-health states in the system,51,52 that we designate 
as resistors (R). Therefore, there is a dynamic tension, 
expressed as [H*R], between holopathogens and resis-
tors as antagonistic force-mechanisms.
Given the predominance of negative expressions in 
established disease notations, let AR = [1 - R] as anti-
resistors. Thus, consider the following classes of vulner-
able states related to disease as AR:
(a) alteration – a
(b) debility – d
(c) weakness – w
(d) susceptibility – s
(e) vulnerability – v
(f) fragility – fg
(g) frailty – fr
Concepts of general susceptibility have been widely 
used in the fields of medicine, epidemiology, biology, 
ecology, engineering, and toxicology, implying 
different emphases that relate to the underlying perspec-
tives and methods of each field.52,58 The same is true for 
vulnerability and fragility concepts, which already have 
a recognized theoretical status in ecosystems research55 
and in social determination models of disease.33,56 On 
the other hand, for decades already, frailty has been used 
as an operational tool for studying the relationship of 
disability related to aging32 and psychosocial aspects 
of health inequality.9
In addition to these concepts, other designations to 
particular conditions of vulnerability can be applied 
to subindividual dimensions of disease-health, such 
as alteration, debility and weakness, absent from the 
specialized literature. In this proposal, the term ‘alter-
ation’ refers to modifications in the microstructure of 
organic units that, at the molecular and cell levels, lead 
an anomaly to become abnormal, or a defect. The terms 
‘debility’ and ‘weakness’ refer to similar processes 
corresponding respectively to the microsystemic and 
subindividual HDI dimensions.
Given these definitions, the notion of HPG outcomes 
may be introduced into the scheme. Consider the 
following notation for HPG outcomes:
(a) defect – Def
(b) lesion – Les
(c) pathology – Pat
(d) disease (or disorder) – Dis
(e) risk – Rsk
(f) hazard – Haz
(g) sickness – Sik
For the different dimensions of HPG, concepts related 
to outcomes (O) of typical pathological states, as well as 
to factors of the sub-groups of HPG forces, respectively 
H and AR (anti-resistors), are presented in the Table.
This scheme may be useful as a background for a gener-
alized model of the complex Disease-Illness-Sickness 
(cDIS) as a network of determination processes of 
phenomena pertaining to health-disease-care in human 
populations. cDIS is composed by antagonistic rela-
tions of pathogenesis and salutogenesis, at distinct sub-
spaces or levels of occurrence, articulated by ‘struc-
tural coupling’,49 designated as holopathogenesis.6 This 
approach supports an primary definition of disease in 
terms of complexity theory:
‘disease’ is a complex, plural and multifaceted 
object, being simultaneously defect, lesion, altera-
tion, pathology, disease, risk, damage, hazard, ill-
ness; ruled by a logic of complexity, subject both 
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to the bio-demographical order and to the sociocul-
tural order; structured as a ‘network of networks’, 
in distinct levels.
As it is proposed to tackle theoretical and method-
ological problems normally avoided by linear and 
fragmented traditional paradigms of pathogenesis, 
such a conceptual framework requires the integra-
tion of several disciplinary approaches into an artic-
ulated and interactive research endeavor. These 
interdisciplinary subspaces, and respective determi-
nation rules, may be represented as contiguities or 
correspondences between object levels, organized as 
interfaces: biomolecular/ /immunological (molecule 
to cell), physiopathological/ /clinical (organ/system 
to body), epidemiological/ /ecosocial (population to 
species). Certainly, the symbolic order permeates all 
sets and subspaces.
In this framework, the HPG concept is construed as 
a special kind of heuristic object-model, operating 
in different hierarchical levels of complexity, simul-
taneously dependent of ontological and symbolic 
substrata.71 Such a model can be applied to different 
classes of HDI-states, which have one or more of the 
facets referred to above more developed than others 
may. Each of the types or groups of disease may 
have a more or less “holopathogenic” prototypical 
format, with their respective semantics and rules of 
syntax between assumptions, levels and dimensions. 
Networks of simultaneous processes of ‘overdeter-
mination’ generate dynamic pathways of pathogen-
esis. Elsewhere,7 I and a colleague have proposed the 
category of overdetermination as useful for helping 
understanding the chain of multiple components, 
factors and vectors that conform cDIS as a scientific 
object of knowledge.
Modeling holopathogenesis
Let ‘ƒ’ be any given facet of cDIS.
Therefore, cDIS may be partially and provisionally 
defined as a set of ƒ-facets of pathogenesis, as
cDIS: [ƒMSt], [ƒMSy], [ƒSbI], [ƒCas], 
[ƒPaR], [ƒEcS], [ƒSoC]... [ƒ]’s
The production of knowledge about pathogenesis 
regarding only one of the ƒ-facets, assuming its isola-
tion from the other facets, will necessarily be partial and 
simplistic. Every ƒ-facet combination and its respec-
tive outcome compose a partial ontological model of 
disease, or a pathogenesis submodel of HDI. Therefore, 
in the light of the framework outlined above, simple, 
straightforward models are destined to fail as a source 
of knowledge needed for effective interventions in 
health situations.
Incomplete definitions of this first HDI ontological 
model might include the summation of ƒ-facets as if 
they all pertain to the same class and order, as in
DIS = Σ(ƒ)
or the simple sum of components of pathogenesis, as 
in Cartesian modeling of
DIS = (Def + Les + Pat + Dis + Rsk + Haz + Sik)
Beyond such partial modeling, let us advance for 
a second-level definition of disease as a complex 
model, as cDIS, respectful of the diversity of 
outcomes and facets and the integrity nature of the 
model-object disease:
cDIS: [ƒMSt(Def)], [ƒMsy(Les)], [ƒSbI(Pat)], 
[ƒCas(Dis)], [ƒPaR(Rsk)],  
[ƒEcS(Haz)], [ƒSoC(Sik)]...
from which we derive a first general holopathogenesis 
(HPG) model:
HPG: [ƒMSt(a→Def)], [ƒMsy(d→Les)], 
[ƒSbI(l→Pat)], [ƒCas(k→Dis)], [ƒPaR(f→Rsk)], 
[ƒEcS(c→Haz)], [ƒSoC(s→Sik)]...
In this model, (→) is the general notation for links 
between determinant and outcome at all levels, compo-
nents and patterns of holopathogenesis, such as:
Table. Dimensions and correlates of Holopathogenesis.
Dimension O: outcome H: holopathogen AR: anti-resistor
MSt Def defect α anomaly a alteration
MSy Les lesion δ defect d debility
SbI Pat pathology λ lesion w weakness
Cas Dis disease (disorder) κ cause s susceptibility
PaR Rsk risk ϕ factor v vulnerability
EcS Haz hazard χ condition fg fragility
SoC Sik sickness σ meaning fr frailty
MSt: Micro-structural; MSy: Micro-systemic; SbI: Subindividual; Cas: Individual; PaR: Epidemiologic; EcS: Environmental; 
SoC: Symbolic.
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(a) microstructural genetic models yield mole-
cule or cell anomalies α leading to cell damages 
Def, or (a→Def);
(b) microsystemic models have metabolic deviations 
or tissue defects δ producing lesions Les, or (d→Les);
(c) physiopathological models have subindividual 
processes manifested as lesions λ which are condi-
tions for producing pathologies Pat, or (l→Pat);
(d) clinical models are built based on organ damage 
or body system failure known as causes κ for cases 
of diseases (or disorders) Dis, or (k→Dis);
(e) epidemiological models are formed by exposure 
or risk factors φ determining risks Rsk, or (f→Rsk);
(f) ecosystem health models are made of possi-
bility components or conditions χ leading to dis-
balanced environmental hazards Haz, or (c→Haz);
(g) semiotic models operate as the interplay of 
signs/meanings/practices σ engendering sickness 
Sik on symbolic grounds SoC, or (s→Sik).
This possibility of a system of sub-spaces is graphi-
cally (and metaphorically) represented in Figure 2 as a 
patchwork of networks, fitting a descriptive modeling 
of, say, determination of depression.
If HPG subspaces were strictly orthogonal, the dynamic 
evolution of each dimensional sub-model would be 
independent of the others. Yet, we could overwrite a 
second general holopathogenesis model with the addi-
tion of all pathogenesis sub-spaces considered, thus 
yielding a less incomplete cDIS model, as in:
cDIS = MSt⊕ MSy ⊕ PPt ⊕ Cas 
⊕ PaR ⊕ EcS ⊕ SyC,
where the symbol ⊕ expresses that, in the mathematical 
formalization of the HPG object, each one of these HPG 
components should be defined in a different subspace. 
This symbol is usually employed to indicate an opera-
tion of ‘direct sum’, which acts on elements belonging 
to orthogonal subspaces, and the result of the operation 
is defined in the space formed by the Cartesian product 
of the two sub-spaces.
The corresponding HPG model can be written as follows:
HPG: [ƒMSt(a→Def)] ⊕ [ƒMsy(d→Les)] ⊕ 
[ƒSbI(l→Pat)] ⊕ [ƒCas(k→Dis)] ⊕ [ƒPaR(f→Rsk)] 
⊕ [ƒEcS(c→Haz)] ⊕ [ƒSoC(s→Sik)]
In this notation, the brackets [•] indicate the dynamic 
evolution within each dimension. Inside the parenthesis, 
different factors of H*R subsets that alter the complex 
system of pathological states cDIS are pointed out. The 
graphical representation of this model as a linear network, 
superimposed by the composite hierarchical order of 
dimensions, holopathogens and outcomes, is in Figure 3.
As concerned with the formalism proposed herewith, 
physiopathological models purely additive imply 
subspaces necessarily orthogonal for the different 
dimensions of HPG. None of such incomplete models 
is representative of complexity because they do not 
allow inter-articulation of the respective submodels. 
Models of this kind are a partial and incomplete repre-
sentation of the complexity of the DIS system of states 
because they do not allow the articulation among the 
submodels of each dimension of HPG.
Assembling knowledge generated by decades of 
research on the determination of each of the pathogen-
esis submodels, this model is represented in Figure 4 
as a network of networks modeling the overdetermi-
nation of depression.
Figure 2. The complex Disease-Illness-Sickness as a patch-network.
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More accurate and efficient modeling of cDIS implies 
the projection of determinant networks over subspaces 
distributed as convergent trajectories of determination 
on a holospace. As seen above, the ways cDIS is deter-
mined are related to the facet/level of the object-model. 
In this model, distinct facets of a complex ontological 
object demand corresponding interconnected heuristic 
models, articulated around a common disease core.8,57
Furthermore, HPG should be an expression of 
complexity for considering the diversity of intraclo-
sure non-linear connections among the submodels 
Def, Les, Pat, Dis, Rsk, Haz, and Sik, applicable 
to several well-studied pathological conditions. 
Indeed, an essential issue for the HPG structure is 
the interconnection between the different submodels 
because components that are outcome of one submodel 
may become determinant for another one. A given 
pathology (or defect, disorder, lesion, disturbance 
or abnormality) that provokes damage or failure in 
a target-organ or body system may act as a cause of 
clinical disease. The increase of clinical cases and 
geographical concentration in a given population may 
represent a risk factor for communicable diseases. This 
argument is inspired in Samaja’s analysis of social 
reproduction of health situation.70
Therefore, the general systemic-dynamic model of HPG 
has to be reformulated in terms of nature of the struc-
tural coupling between sub-models of pathogenesis. 
Figure 3. The complex Disease-Illness-Sickness as a hierarchical network.
Figure 4. The complex Disease-Illness-Sickness as a net-network.
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This can be put forward in two different but comple-
mentary procedures.
The first approach is to replace the sign of sums on 
orthogonal subspaces ⊕ by the sign of interactive 
connections (⇔) amongst the different dimensions of 
HPG, resulting in:
HPG: [MSt(a→Def)] ⇔ [Msy(d→Les)] ⇔ 
[SbI(l→Pat)] ⇔ [Cas(k→Dis)] ⇔ [PaR(f→Rsk)] 
⇔ [EcS(c→Haz)] ⇔ [SoC(s→Sik)]
In this line, we may also consider the HPG model as 
composed by ƒ-i sub-models that conform specific 
classes of determinants, as follows:
HPG: [ƒ1MSt(a→Def)] ⇔ [ƒ2Msy(d→Les)] 
⇔ [ƒ3SbI(l→Pat)] ⇔ [ƒ4Cas(k→Dis)] 
⇔ [ƒ5PaR(f→Rsk)] ⇔ [ƒ6EcS(c→Haz)] 
⇔ [ƒ7SoC(s→Sik)]
Figure 5 is a graphical representation of this model, 
inter-determined by a complex network of networks 
composed by a non-hierarchical, interconnected order 
of dimensions, holopathogens and outcomes. Many of 
the links internal to the sub-models in the sub-spaces 
belong to or are connected to other chains of determi-
nation, in different levels or domains. Such relations 
are articulated by ‘structural coupling’, generated by 
simultaneous processes of ‘over-determination’ of the 
different classes of cDIS.
The second approach to this modeling is to recognize 
that the sub-spaces defined by the different dimensions 
of HPG are not strictly orthogonal, but share determi-
nants and components of the other sub-spaces. This 
situation is implicitly recognized in the Table, where 
concepts as alteration and lesion appear in different 
HPG spaces, either as a HDI-state characteristic of 
the cDIS, or as a determinant of disease-health states 
in the subsequent level. Different symbols are taken 
as reference for such concepts since that, within the 
HPG model, they play roles that are also distinct in the 
dynamic evolution of the system.
Because they are nearly orthogonal, the HPG subspaces 
are interrelated in such a way that the projection of 
subspace (i) on the other subspace (j) does not distin-
guish the individual effects of the subsets Hi and Ri on 
the pathogenic state of j level. This influence will be 
then exercised through a projection of the set of these 
determinants, which can be defined, at a first approach, 
by the values assumed by the state variable of i level.
Indeed, the challenge of offering an appropriate inter-
projection of effects at different scales in modeling health-
disease phenomena is a non-trivial demand to the several 
attempts of approaching complex systems. In general, the 
inter-level projection can be formally written that:
Vti = ƒi (Hi, Ri)
where VTi indicates the temporal variation of the path-
ological state of the i-th HPG dimension, and ƒi is a 
function of the antagonistic subsets Hi and Ri as defined 
above. The interrelation among different dimensions i 
and j of HPG is expressed by a projection operation:
Mij: ({Hi }, {Ri})→({Hj }),
in such a way that the pathological state of the i-th level 
over determinates the pathological factors of the j level. The 
great challenge to the proposed framework relies exactly 
in the determination of the Mij operations of projection.
Figure 5. inter-determination among sub-spaces in the complex Disease-Illness-Sickness.
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The concrete forms of these operations will be drawn 
out of available empirical data in each dimension/
level/facet of HPG, as much as from the accuracy 
with which the different models will be able to repro-
duce and predict situations observed in concrete health 
situations. In this regard, HPG mapping also permits 
the visual representation of the influence of research 
areas and categories on the cDIS model. This is illus-
trated in Figure 6, where it is graphically demonstrated 
how limited in scope and relevance are biomolecular 
research targets as compared to environmental and 
sociocultural conditions for the over-determination of 
health-disease outcomes.
Finally, HPG can be regarded as exemplary of a fractal 
structure, since each of its components can be explored 
as an entire whole system in itself. In this model, the 
ƒ-facets can be considered as fractal dimensions of the 
holopathogenesis concept if we consider that they are 
each a proper determined model-object.
Considering fractality as reiteration of patterns across 
levels, by definition the heteronomic nature of the 
submodels apparently stands against modeling patho-
genesis as a fractal phenomenon. Nevertheless, since 
each dimension is ruled by H*R antagonistic relations, 
one could identify in this general dynamic pattern a 
fractal structure in the overdetermined cDIS system.
Toward a new research agenda
In the conclusion of his book Epistemology of Health, 
Samaja71 comments that holopathogenesis theory 
might be considered as a formal ontology of evolution, 
self-organization, complexity, life, society and culture, 
needed for a unified theory of health-disease-care. 
The great advantage of the HPG approach lies on the 
possibility of allowing a description of special features 
(for instance, of a tissue, of a peculiar immunological 
system, of a local population distribution, of a health 
program or a care system) and an analytical under-
standing of the whole explanatory model, much richer 
in functions and details than those obtained by partial 
differential equations applied to fragmented sections 
of a piecemeal chain of causation.
Research focusing on complex model-objects generated 
by unified theoretical frames has transformed impor-
tant scientific fields of today (such as “the market” for 
economy, “the environment” for ecology, “cosmos” 
for astrophysics and “life” for biology). Creative 
cross-disciplinary efforts aimed at producing synthetic 
models can be used to construct complex objects of this 
kind. Particularly with regard to concrete processes of 
the health reality, better dialogue and articulation across 
the different health disciplines may be a secondary gain 
to consider in developing HPG research strategies.
As stated in the Introduction, the present proposal is 
a theoretical research endeavor that, nevertheless, is 
intended to produce a systematic approach with imme-
diate practical outcomes. Beyond validity of HPG as a 
theoretical construct, dimensions and components must 
be translated into descriptors to allow assessment of 
its operational validity as a complex modeling device. 
In this regard, the definition of holopathogens across 
the planes of occurrence (subindividual, individual 
and supraindividual), as presented in the Table, may 
Figure 6. Research areas of interest in the complex Disease-Illness-Sickness.
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be completed by the equivalent descriptors, as follows 
(Holopathogens/Descriptors): anomaly/state; defect/
condition; lesion/sign or symptom; cause/status; factor/
indicator; condition/situation; meaning/metaphor.
The development of HPG-based strategies may pave the 
way for the adoption of measures much more effective 
for the control of disease and therefore for the promo-
tion and protection of health than the use of straight-
forward sequencing of molecules or bio-information 
particles, naïve narrative therapies or conventional tech-
niques of strategic planning. Conventional proposals 
of modeling disease-health states have typically used 
formal logic and linear equation systems, which can 
vary from a standard deterministic approach to a modi-
fied conditional stochastic formulation.11,19,62
Given the scheme sketched above, a prospective 
research agenda can be proposed. First, we need to 
advance by formalizing intra- and inter-level correspon-
dences, effects and links of HPG models and submodels 
of prototypical classes of cDIS. Treatment of the 
following questions may be considered as intermediate 
goals: How to prepare the submodels for coupling into 
the general HPG models? How to conduct inter-level 
transduction within HPG models? How to operate the 
inter-correspondence of HPG models between distinct 
groups of pathology?
Second, we have to face the challenge of developing 
more refined diagnostic criteria and efficient tools for 
different classes of cDIS.59,75 This implies tackling the 
following regional heuristics: What kind of syntax of 
inter-model articulation should be more feasible and 
efficient heuristically and of better fit vis à vis the 
HPG theory? Which HPG-derived nosological devices 
should be prompted for the analysis of co-occurrence of 
different classes of pathology known as comorbidity? 
Indeed, to conceptualize ‘disease’ in a way that respects 
its integrity and complexity, as possibly achieved by 
HPG modeling, may become one of the essential tasks 
for the health sciences in the near future.18,26,31,35,73,76
The third step is to elaborate, test and standardize 
HPG-oriented research protocols, applicable to 
distinct components and pathogenesis levels. In such 
a research program, every formal advance and instru-
mental development can be validated and tested for 
application regarding distinct classes of pathology. 
This includes graphical tools to visualize HPG concep-
tual mapping as well as computational tools that will 
be needed to operate HPG/FSTD research proto-
cols, applied to the different groups of pathology. 
Eventually, methodological strategies and techno-
logical devices generated from HPG approaches are 
planned to be used for inter-sectorial and transdis-
ciplinary research aimed at a more comprehensive, 
deeper understanding of health problems.5,18,44
Final comments
No doubt, it is time to ask fundamental questions such 
as “what is health?”3,28 and “what is disease?”.65,83 These 
questions are in parallel to the problem of what life 
is, why it is organized the way it is and how and why 
entropic and interactive processes and agents threaten 
bio-processes and survival functions. Nevertheless, 
the rewards in terms of technological advancement 
for disease control strategies should be equivalent to 
the degrees of difficulty found in modeling complexity 
in health research.11,19,23,35,43,46,60,62,73 Disease control in 
this sense is not the mere reduction of prevalence or 
incidence in exposed populations, or cure, healing and 
recovery in persons. It rather implies considering all 
known sets of sensitive points of the etiologic network 
bound to change towards becoming healthier. This will 
be crucial for developing more effective computer 
simulations in each case, and for engineering a new 
generation of knowledge-based technologies applied 
to the control of diseases and promotion of health.26,76 
To some extent, this means to design, apply and test 
technological solutions for HPG simulations, designing 
virtual models of Artificial Pathogenesis analogous to 
Artificial Life approaches.
In sum, this paper is about theory-building on health-
disease-care, pursuing a comprehensive approach to 
death, dysfunction, pathology and suffering. However, 
the logic that rules complex, prospective objects such as 
cDIS is a multiple, non-linear and plural logic that cannot 
be expressed in simple coded form. Therefore, a regional 
epistemology, in Piagetian terms,61 will be needed to 
build an applied theory of knowledge using maps as 
an essential device for HPG research. Generalized and 
unified theories such as HPG may be of vital importance 
as a source of heuristics and of semantic operators needed 
for understanding organization, evolution and determi-
nation of diverse groups of pathology.
Axiomatically, HPG includes assumptions formalized 
in logical-mathematical terms, allowing a multidi-
mensional holodynamics of causation, determination 
and overdetermination of hierarchical structures. As a 
theoretical outline, HPG is translated by net-networks 
of overdetermination processes of health-disease 
phenomena, composed by antagonistic, non-linear 
relations of pathogenesis and salutogenesis, at distinct 
levels or subspaces. To be interpretable in biological, 
clinical and psychosocial terms, it may be formulated 
as an integral system of model-objects, including 
dimensions that are still absent although necessary for 
a rigorous understanding of the complexity of disease 
objects. That this understanding is feasible through 
HPG theory is our preliminary answer.
A generalized or unified theory of pathogenesis is 
indeed necessary for providing a valuable and justified 
frame of reference for a unified comprehensive theory 
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of health and of the living.71 The broad understanding 
of pathogenesis pursued by HPG theory implies the 
possibility of studying and projecting the balance of 
both local and global dynamics in order to achieve 
different levels and definitions of health. Although not 
totally anew in applied theoretical biology, these ques-
tions are at present especially urgent in connection with 
the problems of development of bioinformatics and 
dynamic systems approaches applied to non-discrete, 
un-limited, fuzzy objects of knowledge such as the 
complex object of disease-health-care.
In the biomedical and social health fields, potential 
uses of fuzzy set logic have been proposed for clin-
ical medicine59,75 and for epidemiologic research.48,80 
Only recently, Sadegh-Zadeh and collaborators68,69,75 
have proposed a Fuzzy Set Theory of Health, as an 
approach critical to the notions of boundary and preci-
sion of formal set theory, which has been the logical 
ground to linear, categorical systems still prevailing in 
the analytics of modern science. Further explorations 
on this line of enquiry (forthcoming) will be needed to 
review, adjust and apply a unified theory of health and 
non-health objects based on fuzzy set logic.
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